GSK
GSK’s Arexvy Vaccine Poised for Blockbuster Sales, Besting Pfizer in RSV Market Debut
Pfizer is facing not only a decline in its COVID-19 vaccine sales but also stiff competition from GSK in the ...
GSK’s Jemperli Shows Promise in Endometrial Cancer Trial – FDA Label Expansion on the Horizon
GSK has achieved a significant milestone with its PD-1 inhibitor, Jemperli, in the treatment of endometrial cancer, potentially opening the ...
GSKās RSV vaccine poised for label expansion after trial success
Five months after GSK made history by securing FDA approval for its respiratory syncytial virus (RSV) vaccine, Arexvy, the company ...
ESMO 2023: GSKās Jemperli beats Merckās Keytruda in lung cancer survival trial
In a groundbreaking clinical trial, GSK has achieved remarkable patient survival results with its PD-1 inhibitor, Jemperli, when compared to ...
Pfizerās Penbraya: First vaccine to prevent all five types of meningitis gets FDA approval
Pfizer has secured a significant regulatory victory in the race to introduce the first five-pronged meningitis vaccine in the United ...
GSK and Zhifei team up to distribute Shingrix in China and explore potential collaboration for RSV vaccine
GlaxoSmithKline has entered into a strategic partnership with Chongqing Zhifei Biological Products to distribute its shingles vaccine, Shingrix, in China. ...
Colombia seeks to slash HIV drug costs by overriding ViiVās patent
Colombia has taken a significant step in response to a pricing dispute with GSK’s ViiV Healthcare regarding the HIV medication ...
GSK aims to boost HIV sales to Ā£7B with new drugs and launches
GSK is charting an optimistic course for its HIV business, buoyed by the success of its long-acting antiretroviral therapy, Cabenuva. ...
Pfizer’s Abrysvo Secures CDC Endorsement for Infant Protection, Intensifying RSV Vaccine Competition
Despite GSKās Arexvy pioneering the respiratory syncytial virus (RSV) vaccine landscape earlier this summer, Pfizer has persistently challenged the competition ...
Contamination Worries Prompt Scynexis to Recall Brexafemme, Putting Trials on Hold Following GSKās Manufacturing Review
In a surprising development, Scynexis is taking a precautionary step to withdraw its antifungal medication, ibrexafungerp, marketed as Brexafemme, from ...
Aurinia appoints founder and former CEO Robert Foster to board as part of cooperation agreement with MKT Capital
Aurinia Pharmaceuticals, known for its focus on autoimmune diseases, has taken steps to address investor concerns by appointing its founder ...
Johnson & Johnson and GSK sued for false advertising of decongestant products
A class-action lawsuit has been filed against pharmaceutical giants Johnson & Johnson and Procter & Gamble in a US federal ...
Johnson & Johnson rebrands itself with a new logo and slogan
First Sanofi, GSK, and now Johnson & Johnson are all undergoing significant rebranding efforts in the pharmaceutical industry. In a ...
Orchid Pharma to produce GSK and Shionogiās antibiotic for global access
Orchid Pharma, a subsidiary of India’s Dhanuka Labs, has secured a sublicense to manufacture the antibiotic cefiderocol. This development is ...
CureVac selects mRNA flu vaccine candidate for GSK collaboration, but data remains secret
CureVac, the renowned biotech company, has made a significant stride in its quest to develop an mRNA influenza vaccine. While ...
GSK Teams Up With Ex-Basketball Star To Raise Awareness Of RSV, A Deadly Virus For Babies
GSK is intensifying its campaign to raise awareness about respiratory syncytial virus (RSV) and promote its RSV vaccine, Arexvy. The ...
GSKās Nucala Gets Closer to Approval for Severe Asthma in Japan
GSK has unveiled a ray of hope for millions of Japanese individuals grappling with the debilitating burden of chronic rhinosinusitis ...
GSK boosts vaccine production with ā¬250M facility for shingles, RSV and malaria shots
As GlaxoSmithKline (GSK) continues to expand its vaccine portfolio with the introduction of the new respiratory syncytial virus (RSV) vaccine, ...
Shingrix Maintains Perfect Score in GSK’s Shingles Vaccine Trial in China
In October of the previous year, GlaxoSmithKline (GSK) unveiled an ambitious strategy to double its presence in the Chinese market ...
Pfizer’s Abrysvo Achieves Landmark as First Maternal RSV Vaccine to Safeguard Newborns
Pfizer’s Abrysvo has achieved a groundbreaking milestone by becoming the first vaccine to safeguard newborns against respiratory syncytial virus (RSV) ...
GSK’s Arexvy Takes Lead in RSV Vaccine Race, Now Accessible at Leading US Pharmacies
In the competitive landscape of the respiratory syncytial virus (RSV) vaccine market, GlaxoSmithKline (GSK) stands out with its well-timed strides. ...
GSK signals a marketing pause in Nigeria after taking the same action in Kenya and India
Last week, GSK announced its intention to discontinue the commercialization of its prescription drugs and vaccines in Nigeria, planning to ...
GSK researchers discover a novel method to combat malaria
Source – GSK Researchers at GSK have made a remarkable discovery in the battle against malaria, and it’s not a ...
GSK files a patent infringement lawsuit against Pfizer as the RSV vaccination war begins
In the latest vaccine showdown, GSK and Pfizer are engaged in a legal battle over patent infringement claims. GSK alleges ...
Endometrial Cancer Patients Get New Option with Jemperli
Source – GSK GSK has secured approval from the US for Jemperli, in combination with chemotherapy, as a first-line treatment ...
GSK lowers short-term hopes for RSV treatment Arexvy but raises 2023 forecast
Great expectations surround GSK’s entry into the respiratory syncytial virus (RSV) vaccine market with their upcoming shot, Arexvy, set to ...
GSKās Arexvy and Modernaās mRNA-1345 to lead the race for RSV prevention
The respiratory syncytial virus (RSV) is a common cause of respiratory infections, especially in infants and older adults. It can ...
GSK-Financed Study Shows Global Decline in Adult Immunization Rates
Despite the widespread attention given to COVID-19 vaccines in recent times, there has been a significant decline in the uptake ...
GSK Recalls Nucala in Taiwan Due to Glass Particles – Breaking News!
When it comes to drug packaging, a vial is typically seen as a separate entity from the product it contains. ...
GSK’s Star-Studded Reunion Amplifies Meningitis Awareness Campaign
GSK has brought together Soleil Moon Frye and Melissa Joan Hart, stars of “Sabrina the Teenage Witch,” for its latest ...
